Showing 3911-3920 of 5646 results for "".
- Apellis Provides Update on Review of Safety Events with Syfovre for Geographic Atrophyhttps://modernod.com/news/apellis-provides-update-on-review-of-safety-events-with-syfovre-for-geographic-atrophy/2481755/Apellis Pharmaceuticals provided an update on its review of rare events of retinal vasculitis reported in real-world treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). “The safety of patients has always
- Shamir Insight Launches 'Driver Intelligence' Lens Technologyhttps://modernod.com/news/shamir-insight-launches-driver-intelligence-lens-technology/2481754/Shamir Insight announced the launch of Driver Intelligence, a lens technology designed to optimize visual performance and deliver superior clarity for drivers any time of the day, enabling safer driving. Shamir Insight worked closely with the Renault
- Okyo Pharma’s OK-101 Will Be Evaluated to Treat Neuropathic Corneal Pain in Study at Tuftshttps://modernod.com/news/okyo-pharmas-ok-101-will-be-evaluated-to-treat-neuropathic-corneal-pain-in-study-at-tufts/2481753/Okyo Pharma, which is developing OK-101 to treat the symptoms of dry-eye disease (DED), announced an agreement with Tufts Medical Center in Boston to conduct a 40-patient, open-label, clinical trial evaluating the efficacy and safety of OK-101 in patients with neuropathic corneal pain (NCP)
- HelpMeSee and USAID Partner to Train New Cataract Specialists to Provide Surgical Care for India's Cataract Blindhttps://modernod.com/news/helpmesee-and-usaid-partner-to-train-new-cataract-specialists-to-provide-surgical-care-for-indias-cataract-blind/2481752/HelpMeSee announced a new partnership with the United States Agency for International Development (USAID) American Schools and Hospitals Abroad (ASHA) initiative to train 100 new cataract specialists to help restore sight to India's cataract blind. Through this agreement, ASHA has p
- Glauconix Changes Name to Humonixhttps://modernod.com/news/glauconix-changes-name-to-humonix/2481751/Glauconix Biosciences has changed its name to Humonix Biosciences as the company has expanded beyond glaucoma to technology can support various cell types. "What began as a specialization in glaucoma therapeutics has become a launchpad for developing new fibrotic and vascular
- Verséa Ophthalmics Will Distribute Celularity’s Biovance and Biovance 3L Ocular Products in the United Stateshttps://modernod.com/news/versea-ophthalmics-will-distribute-celularitys-biovance-and-biovance-3l-ocular-products-in-the-united-states/2481750/Celularity and Verséa Ophthalmics announced that the companies have entered into an exclusive United States commercialization agreement under which Verséa will distribute Celularity’s Biovance and Biovance 3L ocular products. The products are designed to support the
- AsclepiX Therapeutics Raises $10 Million to Advance Phase 1/2a Clinical Study of AXT107https://modernod.com/news/asclepix-therapeutics-raises-10-million-to-advance-phase-12a-clinical-study-of-axt107/2481749/AsclepiX Therapeutics announced that it has secured a $10 million Series A-3 financing to advance clinical development of its lead candidate, AXT107 (gersizangitide), in patients with wet AMD. “With the completion of this round, we are excited to embark into the next phase of
- Optometry and Vision Science Names New Editor-in-Chiefhttps://modernod.com/news/optometry-and-vision-science-announces-new-editor-in-chief/2481744/The American Academy of Optometry (AAO) announced that David Elliott, PhD, FCOptom, FAAO, is the new editor-in-chief of Optometry and Vision Science (OVS). Mr. Elliott succeeds Michael Twa, OD, PhD, FAAO, who is stepping down from the role after 7 years.
- Study Identifies How Diabetes Slows Healing in the Eyehttps://modernod.com/news/study-identifies-how-diabetes-slows-healing-in-the-eye/2481742/Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea, according to a company news release.
- RestoringVision Appoints of Three Directors to its Leadership Teamhttps://modernod.com/news/restoringvision-appoints-of-three-directors-to-its-leadership-team/2481739/Nonprofit RestoringVision announced the appointment of three directors to its leadership team to strengthen its impact in solving the global vision crisis. This follows a year of growth, in which RestoringVision expanded its reach by 48 percent in 2022. In 2023, the organization aims to reac